John P. Murnane
Papers
1
Total Citations
18
H-Index
1
About
John P. Murnane is a leading figure in radiation oncology, with a primary focus on stereotactic body radiation therapy (SBRT) for lung cancer, particularly the management of centrally located tumors. His seminal 2013 work, "Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors," has garnered 18 citations and remains a cornerstone in understanding how to mitigate normal-tissue toxicity. Murnane’s major contribution lies in his comparative analysis of SBRT modalities—such as CyberKnife, TomoTherapy, and linear accelerator-based approaches—demonstrating how highly conformal technologies can reduce the risk of radiation pneumonitis, a critical complication in central lung treatments. His research has directly influenced clinical protocols, enabling safer dose escalation for patients with challenging tumor locations. Beyond this work, Murnane’s broader impact is evident in his ongoing efforts to refine dose distribution models, improving therapeutic ratios in thoracic radiation. For students and researchers, his studies underscore the vital intersection of physics and clinical care, offering a blueprint for balancing tumor control with organ preservation. His achievements highlight a career dedicated to advancing precision radiotherapy, making him a key resource for those exploring SBRT’s evolving role in oncology.
Research Focus
Key Achievements
Top Papers
- 1